Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease intestinal disease
Comorbidity C0009402|colorectal carcinoma
Sentences 2
PubMedID- 21689324 Aim: the study assessed the clinicopathological features and survival rates of inflammatory bowel disease (ibd) patients with colorectal carcinoma (crc), which accounts for approximately 15% of all ibd associated death.
PubMedID- 20128025 Aim: to assess patients' understanding for the reasons for taking 5-aminosalicylic acid or ursodeoxycholic acid as chemoprophylaxis against colorectal carcinoma associated with inflammatory bowel disease (ibd).

Page: 1